Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents

Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents

Background/Purpose: Direct-acting antiviral agents (DAAs) have revolutionized the paradigm for HCV treatment. However, patients with HBV and HCV co-infection receiving DAAs are at significant risk of HBV reactivation, with limited literature addressing the roles of serum chemokines/chemokines. We ai...

Full description

Bibliographic Details
Main Authors: Shang-Chin Huang, Pin-Nan Cheng, Chen-Hua Liu, Hung-Chih Yang, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao, Chun-Jen Liu
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Journal of the Formosan Medical Association
Subjects:
Acute flare
Co-infection
TNF-alpha
C–C motif chemokine ligand 2
Interferon-gamma
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664621004241

Internet

http://www.sciencedirect.com/science/article/pii/S0929664621004241

Similar Items